INDIVIDUAL VARIABILITY IN DRUG METABOLISM BY CARBON DIOXIDE BREATH TESTS
INDIVIDUAL VARIABILITY IN DRUG METABOLISM BY CARBON DIOXIDE BREATH TESTS
批准号:
3813488
负责人:
D LALKA
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
preliminary testing of the prediction that caffeine, a low extraction
ration drug (0.1) should be a more sensitive probe of enzyme inducttion
than methacetin, a high extraction ration drug (0.9), when excretion of a
metabolite (C02) is measured has been carried out. A single dose of each
was administered to 8 healthy volunteers and 9 epilepsy patients treated
with phenytoin, carbarazepine and/or phenobarbital. The 13C carbon dioxide
in expired breath was measured y isotope ratio mass spectrometry. The
percentages of the dose excreted as CO2 in 2 hr. were compared: 3.22% +
0.86 and 5.54% + 1.59 caffeine was excreted by controls and patients,
respectively, compared with 28.6% + 5.8 and 40.0% + 4.2 methacetin. The
results in the 2 subject groups were significantly different for both
probes (p<.05). These data do not support the theoretical prediction that
the extraction ratio of a drug has a critical effect upon its usefulness in
detection of induction of oxidative metabolism via the carbon dioxide
breath test. In addition, preliminary data illustrate the potential
usefulness of this test to follow the time course of changes in drug
metabolism/liver function of an alcoholic patient when he stops drinking.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INDIVIDUAL VARIABILITY IN DRUG METABOLISM BY CARBON DIOXIDE BREATH TESTS
-
批准号:3808647
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D LALKA
-
依托单位: